Stonnington Group’s Bristol-Myers Squibb BMY Stock Holding History

Stonnington Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$2.53M	Sell	35,845 -2,396	-6%	-$169K	0.66%	39
2022 Q4	$2.74M	Sell	38,241 -4,197	-10%	-$316K	0.76%	35
2022 Q3	$3.02M	Buy	42,438 +304	+0.7%	+$22.1K	0.85%	30
2022 Q2	$3.17M	Buy	42,134 +3,528	+9%	+$269K	0.84%	30
2022 Q1	$2.95M	Buy	38,606 +6,742	+21%	+$453K	0.71%	39
2021 Q4	$2.09M	Sell	31,864 -3,960	-11%	-$232K	0.45%	64
2021 Q3	$2.05M	Sell	35,824 -3,560	-9%	-$234K	0.46%	58
2021 Q2	$2.63M	Buy	39,384 +3,100	+9%	+$202K	0.58%	48
2021 Q1	$2.34M	Buy	+36,284	New	+$2.26M	0.57%	50

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Stonnington Group's BMY Position: Q1 2023 in Review

Stonnington Group reduced its Bristol-Myers Squibb (BMY) stake by 6.3% in Q1 2023, selling an estimated $169K and leaving 35,845 shares worth $2.53M. The position accounts for 0.66% of the portfolio, ranked #39.

Stonnington Group first reported a position in BMY in Q1 2021 and has held it in 9 quarters since. The position peaked at $3.17M in Q2 2022. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Stonnington Group held 35,845 shares of Bristol-Myers Squibb worth $2.53M as of Q1 2023.
Stonnington Group sold 2,396 Bristol-Myers Squibb shares in Q1 2023, an estimated $169K.
Bristol-Myers Squibb made up 0.66% of Stonnington Group's portfolio in Q1 2023, its #39 holding.
Stonnington Group first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 9 quarters since.
Stonnington Group's Bristol-Myers Squibb position peaked at $3.17M in Q2 2022.
2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.